BenefitsPRO: Employee Benefits News, Trends & Sales Tips

What will the Fed make of the softening job market in May?

By Richard Berger

The Federal Reserve will likely hike interest rates by .25 points on May 3, though a recession is highly unlikely without a rise in the unemployment rate, according to an industry researcher.

Read Story

Market Insights

Navigating health care post-COVID: 3 ways to help hold the line on costs

Market Insights

Biogen used 'charity giving' to illegally boost drug sales, Humana alleged in lawsuit

Recommended Just For You

Market Insights Stories

April 12, 2023

No-cost preventive services are now in jeopardy: Implications of the ACA ruling

Insurers and employers are expected to be reluctant or even unable to immediately begin charging copays or deductibles for the affected preventive care for certain services, such as screening for diabetes, hepatitis and certain cancers.

Read

April 11, 2023

What can insurers learn from millennials' obsession with pet insurance?

The likelihood of consumers purchasing insurance for valuables, pets and households varies based on age, education and location.

Read

April 10, 2023

Humira biosimilars are finally here: What brokers and TPAs need to know

Employers, brokers and TPAs need to calibrate their expectations for how Humira biosimilars will impact the cost of prescription drugs for groups and members.

Read

April 10, 2023

ACA record enrollment: Too many patients, not enough doctors?

Many insurers are offering smaller networks of doctors and hospitals, and problems arise when patients cannot find local in-network providers and must pay more for out-of-network care or travel farther for in-network care.

Read

April 07, 2023

Patients are getting blindsided by 'facility fees,' and states are taking action

About half of all patients are getting hit with facility fees, which are billed for doctor visits at hospital-owned clinics, as three in four physicians are now employed by hospitals, health systems or other corporate entities.

Read

April 07, 2023

Xanax and Adderall's 'secret drug limits' due to opioid settlement with top 3 distributors

The limits stem from an opioid settlement with AmerisourceBergen, Cardinal Health and McKesson that flag and sometimes block controlled substances – and patients with anxiety and sleep disorder are caught in the crosshairs.

Read

April 07, 2023

'Loud layoffs' at tech companies are sending mixed messages to other employers

The recent high-profile layoffs at Apple, Google and Microsoft may make it seem like the labor market is in trouble, but six in 10 employers say they are not planning layoffs, according to a new report.

Read

‹ ‹ PREV 90 91 92 ... 214 › NEXT ›

Market Insights

Top Market Insights Stories

What will the Fed make of the softening job market in May?

Navigating health care post-COVID: 3 ways to help hold the line on costs

Biogen used 'charity giving' to illegally boost drug sales, Humana alleged in lawsuit

Recommended Just For You

Market Insights Stories

No-cost preventive services are now in jeopardy: Implications of the ACA ruling

What can insurers learn from millennials' obsession with pet insurance?

Humira biosimilars are finally here: What brokers and TPAs need to know

ACA record enrollment: Too many patients, not enough doctors?

Patients are getting blindsided by 'facility fees,' and states are taking action

Xanax and Adderall's 'secret drug limits' due to opioid settlement with top 3 distributors

'Loud layoffs' at tech companies are sending mixed messages to other employers